UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarter ended November 30, 2017August 31, 2022

 

OR

 

¨

TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to _______________

 

Commission File No. 333-196663000-55965

 

GRIPEVINE INC.flooidCX Corp.

(Exact Namename of Registrantregistrant as Specifiedspecified in Its Charter)its charter)

 

Nevada

 

35-2511643

(State of Other Jurisdictionother jurisdiction

of Incorporationincorporation or Organization)organization)

 

(I.R.S. Employer

Identification Number)

 

1282A Cornwall Road14747 N Northsight Blvd

Oakville, Ontario

CanadaSte 111-218 Scottsdale, AZ

 

L6J 7W585260

(Address of Principal Executive Offices)principal executive offices)

 

(Zip Code)

 

(855) 474-7384(702) 323-6455

(Registrant’s Telephone Number, Including Area Code)

 

CopiesSecurities registered pursuant to:

Sichenzia Ross Ference Kesner LLP

1185 Avenue Section 12(b) of the Americas, 37th FloorAct: None

New York, NY 10036

Attn: Greg Sichenzia, Esq.,

Jay Yamamoto, Esq.

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer

¨

Accelerated filer

¨

Non-accelerated filerFiler

¨

Smaller reporting company

x

 

Emerging growth company

x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

As of January 15, 2018,October 1, 2022, there were 124,720,5322,020,871 shares of our common stock issued and outstanding, par value $0.001.

 

 

 

TABLE OF CONTENTS

 

 

Page

Page

 

Cautionary Note Concerning Forward-Looking Statements

 

3

 

PART I – FINANCIAL INFORMATION

 

Item 1.

Unaudited Interim Condensed CombinedConsolidated Financial Statements

 

4

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and PlanResults of Operations

 

5

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

98

 

Item 4.

Controls and Procedures

 

98

 

PART II – OTHER INFORMATION

 

Item 1.

Legal Proceedings

 

10

 

Item 1A.

Risk Factors

 

109

 

Item 2.

Unregistered SaleSales of Equity Securities and Use of Proceeds

 

109

 

Item 3.

Defaults Upon Senior Securities

 

119

 

Item 4.

Mine Safety Disclosures

 

119

 

Item 5.

Other Information

 

119

 

Item 6.

Exhibits

 

1210

 

SIGNATURES

 

1311

 

 
2

Table of Contents

  

Cautionary Note Concerning Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains "forward -looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended.“forward-looking statements”. These forward-looking statements, including without limitation forward-looking statements made under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” involve risks and uncertainties. Any statements contained in this Quarterly Report that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements include, without limitation, statements as to our future operating results; seasonality expectations; plans for the development, utilization or disposalmarketing of manufacturing facilities;our services; future economic conditions; our expectations as to legal proceedings; the effect of our market and product development efforts; and expectations or plans relating to the implementation or realization of our strategic goals and future growth, including through potential future acquisitions. Forward-looking statements may include, among other things, statements relating to future sales, earnings, cash flow, results of operations, use of cash and other measures of financial performance, as well as statements relating to future dividend payments. Other forward-looking statements may be identified through the use of words such as “believes,” “anticipates,” “may,” “should,” “will,” “plans,” “projects,” “expects,” “expectations,” “estimates,” “predicts,” “targets,” “forecasts,” “strategy,” and other words of similar meaning in connection with the discussion of future operating or financial performance. These statements are based on current expectations, estimates and projections about the industries in which we operate, and the beliefs and assumptions made by management. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances that are difficult to predict. Accordingly, the Company’s actual results may differ materially from those contemplated by the forward-looking statements. Investors, therefore, are cautioned against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Readers should refer to the discussions under “Risk Factors” contained in our Annual Report on Form 10-K for the fiscal year ended February 28, 20172021 concerning certain factors that could cause our actual results to differ materially from the results anticipated in such forward-looking statements. These Risk Factors are hereby incorporated by reference into this Quarterly Report.

 

 
3

Table of Contents

  

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

Interim FLOOIDCX CORP.

Condensed CombinedConsolidated Financial Statements

Three and Six Months Ended August 31, 2021 and 2022

(Expressed in US dollars)

(unaudited)

 

Gripevine, Inc.

For The Quarterly Period Ended November 30, 2017

4
Table of Contents

Gripevine, Inc.

Interim Condensed Combined Financial Statements

For The Quarterly Period Ended November 30, 2017 (Unaudited)

Table of contents

Interim Condensed Combined Balance Sheets

 

 

F-2

Index

 

 

 

 

 

Condensed Consolidated Balance Sheets

F–1

 

Interim Condensed CombinedConsolidated Statements of Operations and Comprehensive Loss

 

F–2

Condensed Consolidated Statement of Stockholders’ Deficit

F–3

Condensed Consolidated Statements of Cash Flows

F–4

Notes to the Condensed Consolidated Financial Statements

F–5

4

Tableof Contents

FLOOIDCX CORP.

Condensed Consolidated Balance Sheets

(Expressed in U.S. dollars)

 

 

August 31,

 

 

February 28,

 

 

 

2022

 

 

2022

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

Cash

 

$221

 

 

$332

 

Prepaid Expenses and Deposits

 

 

1,270

 

 

 

 

Current Assets of Discontinued Operations

 

 

 

 

 

7,988

 

 

 

 

 

 

 

 

 

 

Total Current Assets

 

 

1,491

 

 

 

8,320

 

 

 

 

 

 

 

 

 

 

Property and Equipment, Net (Note 3) - Discontinued Operations

 

 

 

 

 

12,195

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$1,491

 

 

$20,515

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accounts Payable and Accrued Liabilities

 

$16,387

 

 

$40,478

 

Loans Payable (Note 4)

 

 

2,800,863

 

 

 

3,436,010

 

Due to Related Party (Note 5)

 

 

1,179,262

 

 

 

117,491

 

Current Liablilites of Discontinued Operations

 

 

 

 

 

1,443,493

 

 

 

 

 

 

 

 

 

 

Total Current Liabilities

 

 

3,996,512

 

 

 

5,037,472

 

 

 

 

 

 

 

 

 

 

Total Liabilities

 

 

3,996,512

 

 

 

5,037,472

 

 

 

 

 

 

 

 

 

 

Stockholders' Deficit

 

 

 

 

 

 

 

 

Preferred Stock - $0.001 Par; 20,000,000 Shares Authorized, 

 

 

 

 

 

 

 

 

  1,000,000 Issued and Outstanding

 

 

1,000

 

 

 

1,000

 

Common Stock - $0.001 Par; 300,000,000 Shares Authorized, 

 

 

 

 

 

 

 

 

   2,020,871 Issued and Outstanding

 

 

2,021

 

 

 

2,021

 

Common Stock Issuable (Note 6)

 

 

19,616

 

 

 

19,616

 

Additional Paid-In-Capital

 

 

45,111,648

 

 

 

51,875,727

 

Accumulated Other Comprehensive Income

 

 

94,500

 

 

 

88,895

 

Accumulated Deficit

 

 

(49,223,806)

 

 

(57,004,216)

 

 

 

 

 

 

 

 

 

Total Stockholders' Deficit

 

 

(3,995,021)

 

 

(5,016,957)

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders' Deficit

 

$1,491

 

 

$20,515

 

(The accompanying notes are an integral part of these condensed consolidated financial statements)

F-1

Table of Contents

FLOOIDCX CORP.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Expressed in U.S. dollars)

(Unaudited)

 

 

For the Three Months Ended

 

 

For the Six Months Ended

 

 

 

August 31,

 

 

August 31,

 

 

August 31,

 

 

August 31,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

 

 

$

 

 

$

 

 

$3,870

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and Administrative

 

 

(18,739)

 

 

13,811

 

 

 

9,811

 

 

 

47,753

 

Research and Development

 

 

 

 

 

15,626

 

 

 

 

 

 

97,302

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Operating Expenses

 

 

(18,739)

 

 

29,437

 

 

 

9,811

 

 

 

145,055

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) Before Other Expense

 

 

18,739

 

 

 

(29,437)

 

 

(9,811)

 

 

(141,185)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financing Costs

 

 

(3,701)

 

 

(2,174)

 

 

(7,983)

 

 

(3,780)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) for the Period from Continuing Operations

 

 

15,038

 

 

 

(31,611)

 

 

(17,794)

 

 

(144,965)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss from Discontinued Operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Loss on Discontinued Operations

 

 

 

 

 

(100,035)

 

 

(173,201)

 

 

(267,059)

Loss from Spin off

 

 

(2,504,710)

 

 

 

 

 

(2,504,710)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss from Discontinued Operations

 

 

(2,504,710)

 

 

(100,035)

 

 

(2,677,911)

 

 

(267,059)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss for the Period

 

 

(2,489,672)

 

 

(131,646)

 

 

(2,695,705)

 

 

(412,024)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Comprehensive Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign Currency Translation Gain (Loss) on Continuing Operations

 

 

73,730

 

 

 

(20,252)

 

 

75,470

 

 

 

2,455

 

Foreign Currency Translation Gain (Loss) on Discontinued Operations

 

 

 

 

 

201,318

 

 

 

(27,776)

 

 

(19,947)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive Income (Loss) for the Period

 

$(2,415,942)

 

$49,420

 

 

$(2,648,011)

 

$(429,516)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Number of Common Shares -

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  Basic and Diluted

 

 

2,020,871

 

 

 

1,952,657

 

 

 

2,020,871

 

 

 

1,961,748

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) for the Period Per Common Shares -

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  Basic and Diluted Income (Loss) from Continuing Operations

 

$0.01

 

 

$(0.02)

 

$(0.01)

 

$(0.07)

  Basic and Diluted Loss from Discontinued Operations

 

 

(1.24)

 

 

(0.05)

 

 

(1.33)

 

 

(0.14)

(The accompanying notes are an integral part of these condensed consolidated financial statements)

F-2

Table of Contents

FLOOIDCX CORP.

Condensed Consolidated Statements of Stockholders’ Deficit

(Expressed in U.S. dollars)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

Preferred Stock

 

 

Common Stock

 

 

 

 

 

Additional

 

 

Other

 

 

 

 

 

Total

 

 

 

$0.001 Par

 

 

$0.001 Par

 

 

Common Stock

 

 

Paid-In

 

 

Comprehensive

 

 

Accumulated

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Issuable

 

 

Capital

 

 

Income

 

 

Deficit

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - March 1, 2021

 

 

1,000,000

 

 

$1,000

 

 

 

1,976,218

 

 

$1,976

 

 

$19,497

 

 

$51,728,412

 

 

$74,510

 

 

 

(56,165,383)

 

$(4,339,988)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares Returned and Cancelled

 

 

 

 

 

 

 

 

(23,561)

 

 

(23)

 

 

 

 

 

23

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value of Shares to be Issued for Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,355

 

 

 

 

 

 

 

 

 

 

 

 

10,355

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value of Stock Options Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

89,887

 

 

 

 

 

 

 

 

 

89,887

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign Exchange Translation Loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(198,558)

 

 

 

 

 

(198,558)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss for the Period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(280,378)

 

 

(280,378)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - May 31, 2021

 

 

1,000,000

 

 

 

1,000

 

 

 

1,952,657

 

 

 

1,953

 

 

 

29,852

 

 

 

51,818,322

 

 

 

(124,048)

 

 

(56,445,761)

 

 

(4,718,682)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value of Shares to be Issued for Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,908

 

 

 

 

 

 

 

 

 

 

 

 

9,908

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value of Stock Options Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,718

 

 

 

 

 

 

 

 

 

5,718

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign Exchange Translation Gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

181,066

 

 

 

 

 

 

181,066

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss for the Period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(131,646)

 

 

(131,646)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - August 31, 2021

 

 

1,000,000

 

 

$1,000

 

 

 

1,952,657

 

 

$1,953

 

 

$39,760

 

 

$51,824,040

 

 

$57,018

 

 

 

(56,577,407)

 

$(4,653,636)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - March 1, 2022

 

 

1,000,000

 

 

$1,000

 

 

 

2,020,871

 

 

$2,021

 

 

$19,616

 

 

$51,875,727

 

 

$88,895

 

 

 

(57,004,216)

 

$(5,016,957)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign Exchange Translation Loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(26,037)

 

 

 

 

 

(26,037)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss for the Period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(206,034)

 

 

(206,034)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - May 31, 2022

 

 

1,000,000

 

 

 

1,000

 

 

 

2,020,871

 

 

 

2,021

 

 

 

19,616

 

 

 

51,875,727

 

 

 

62,858

 

 

 

(57,210,250)

 

 

(5,249,028)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign Exchange Translation Gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

73,730

 

 

 

 

 

 

73,730

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Spin off

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,764,079)

 

 

(42,088)

 

 

10,476,116

 

 

 

3,669,949

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss for the Period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,489,672)

 

 

(2,489,672)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - August 31, 2022

 

 

1,000,000

 

 

$1,000

 

 

 

2,020,871

 

 

$2,021

 

 

$19,616

 

 

$45,111,648

 

 

$94,500

 

 

 

(49,223,806)

 

$(3,995,021)

(The accompanying notes are an integral part of these condensed consolidated financial statements)

F-3

Table of Contents

FLOOIDCX CORP.

Condensed Consolidated Statements of Cash Flows

(Expressed in U.S. dollars)

(Unaudited)

For the Six Months Ended August 31,

 

2022

 

 

2021

 

 

 

 

 

 

 

 

Cash Flows from Operating Activities

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) for the Period

 

$(2,695,705)

 

$(412,024)

 

 

 

 

 

 

 

 

 

Non-Cash Adjustments:

 

 

 

 

 

 

 

 

Depreciation

 

 

810

 

 

 

2,209

 

Financing Costs

 

 

7,983

 

 

 

3,780

 

Shares Issued/Issuable for Services

 

 

 

 

 

20,263

 

Stock Based Compensation

 

 

 

 

 

95,605

 

Gain from Spin off

 

 

2,504,710

 

 

 

 

Changes in Assets and Liabilities:

 

 

 

 

 

 

 

 

Accounts Receivable

 

 

 

 

 

7,380

 

Prepaid Expenses and Deposits

 

 

(1,300)

 

 

(5,875)

Accounts Payable and Accrued Liabilities

 

 

33,263

 

 

 

7,446

 

Due to Related Parties

 

 

74,710

 

 

 

108,832

 

 

 

 

 

 

 

 

 

 

Net Cash Flows Used In Operating Activities

 

 

(75,529)

 

 

(172,384)

 

 

 

 

 

 

 

 

 

Cash Flows from Investing Activities

 

 

 

 

 

 

 

 

Cash Disbursement - Spin off

 

 

(1,460)

 

 

 

 

 

 

 

 

 

 

 

 

Net Cash Flows Used In Investing Activities

 

 

(1,460)

 

 

 

 

 

 

 

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

 

 

 

 

 

Proceeds from Loans Payable

 

 

83,699

 

 

 

51,114

 

Proceeds from Related Party Loans

 

 

 

 

 

102,967

 

 

 

 

 

 

 

 

 

 

Net Cash Flows Provided By Financing Activities

 

 

83,699

 

 

 

154,081

 

 

 

 

 

 

 

 

 

 

Effects of Foreign Exhange Rate Changes on Cash

 

 

(6,821)

 

 

17,746

 

 

 

 

 

 

 

 

 

 

Net Change in Cash

 

 

(111)

 

 

(557)

 

 

 

 

 

 

 

 

 

Cash - Beginning of Period

 

 

332

 

 

 

1,251

 

 

 

 

 

 

 

 

 

 

Cash - End of Period

 

$221

 

 

$694

 

 

 

 

 

 

 

 

 

 

Cash Paid During the Period for:

 

 

 

 

 

 

 

 

Interest

 

$

 

 

$

 

Income Taxes

 

$

 

 

$

 

(The accompanying notes are an integral part of these condensed consolidated financial statements)

F-4

Table of Contents

FLOOIDCX CORP.

Notes to the Condensed Consolidated Financial Statements

Six Months Ended August 31,2022

(Expressed in U.S. Dollars)

(Unaudited)

1. Nature of Operations and Continuance of Business

FlooidCX Corp. (formerly Gripevine, Inc. and Baixo Relocation Services, Inc.) (the “Company”) was incorporated in the state of Nevada on January 7, 2014. The Company is in the business of developing and building an online resolution platform.

These condensed consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, creditors, and related parties, and the ability of the Company to obtain necessary equity financing to continue operations, and ultimately the attainment of profitable operations. As of August 31, 2022, the Company has a working capital deficit of $3,995,021 and an accumulated deficit of $49,223,806 since inception. As of August 31, 2022, the Company is in default of certain loans payable (refer to Note 4). Furthermore, during the six months ended August 31, 2022, the Company used $75,529 in operating activities. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

2. Significant Accounting Policies

(a) Basis of Presentation

These condensed consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars. These consolidated financial statements include the accounts of the Company and the following entities:

MBE Holdings Inc. – Spinoff June 27, 2022 (See Note 7)

Wholly-owned subsidiary

Resolution 1, Inc

Wholly-owned subsidiary

All inter-company balances and transactions have been eliminated.

(b) Interim Financial Statements

The accompanying condensed consolidated financial statements of the Company should be read in conjunction with the consolidated financial statements and accompanying notes filed with the U.S. Securities and Exchange Commission in the Company’s Annual Report on Form 10-K for the fiscal year ended February 28, 2022. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments of a recurring nature considered necessary to present fairly the Company’s financial position and the results of its operations and its cash flows for the periods shown.

The preparation of these condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. The results of operations and cash flows for the periods shown are not necessarily indicative of the results to be expected for the full year.

F-5

Table of Contents

2. Significant Accounting Policies (continued)

(c) Recent Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments, which changes the impairment model for most financial assets. This Update is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The underlying premise of the Update is that financial assets measured at amortized cost should be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The allowance for credit losses should reflect management’s current estimate of credit losses that are expected to occur over the remaining life of a financial asset. The income statement will be affected for the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. The new standard is effective for fiscal years and interim periods within those years beginning after December 15, 2022.

The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

3. Property and Equipment

August 31,

2022

$

February 28,

2022

$

 

 

 

 

 

 

Interim Condensed Combined Statements of Cash FlowsComputer equipment

-

 

 

40,491

F-4

Furniture and equipment

-

40,543

 

 

 

 

 

 

Notes to Interim Condensed Combined Financial StatementsTotal

-

 

 

81,034

F-5

Less: accumulated depreciation

 

-

(68,839)

Net carrying value

-

12,195

4. Loans Payable

 

F-1
(a) At August 31, 2022, the Company owed $2,240,243 (February 28, 2022 – $2,295,443) which is non-interest bearing, unsecured, and due on demand.

 

Gripevine, Inc.

INTERIM CONDENSED COMBINED BALANCE SHEETS

AS AT NOVEMBER 30, 2017 (UNAUDITED) AND FEBRUARY 28, 2017 (AUDITED)

(Expressed in US dollars)

(b) At August 31, 2022, the Company owed $560,620 (February 28, 2022 – $660,192) which is unsecured, non-interest bearing, unsecured, and due on demand.

 

 

 

As at

November 30,

2017

 

 

As at

February 28,

2017

 

 

 

$

 

 

$

 

CURRENT ASSETS

 

 

 

 

 

 

Cash

 

 

153,082

 

 

 

32,678

 

Prepaid and other receivables

 

 

31,791

 

 

 

20,281

 

Total current assets

 

 

184,873

 

 

 

52,959

 

 

 

 

 

 

 

 

 

 

Equipment [Note 5]

 

 

37,009

 

 

 

41,655

 

TOTAL ASSETS

 

 

221,882

 

 

 

94,614

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

Accounts payable

 

 

26,683

 

 

 

22,325

 

Accrued liabilities

 

 

28,083

 

 

 

78,827

 

Loans payable [Note 6]

 

 

2,046,526

 

 

 

1,822,953

 

Due to related parties [Note 6]

 

 

174,904

 

 

 

178,906

 

Due to a shareholder [Note 6]

 

 

654,357

 

 

 

568,547

 

TOTAL LIABILITIES

 

 

2,930,553

 

 

 

2,671,558

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' DEFICIENCY

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value, 20,000,000 authorized. 1,000,000 shares issued and outstanding as at November 30, 2017 and February 28, 2017 [Note 7]

 

 

1,000

 

 

 

1,000

 

Common stock, $0.001 par value, 300,000,000 authorized, 124,720,532 and 120,000,000 shares issued and outstanding as at November 30, 2017 and February 28, 2017, respectively [Note 7]

 

 

124,721

 

 

 

120,000

 

Common stock to be issued [Note 7]

 

 

3,022

 

 

 

5,249

 

Additional paid-in-capital

 

 

45,313,192

 

 

 

43,698,125

 

Accumulated other comprehensive income

 

 

129,346

 

 

 

233,651

 

Accumulated deficit

 

 

(48,279,952)

 

 

(46,634,969)

Total stockholders' deficiency

 

 

(2,708,671)

 

 

(2,576,944)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY

 

 

221,882

 

 

 

94,614

 

 

 

 

 

 

 

 

 

 

Commitments [Note 9]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Subsequent events [Note 10]

 

 

 

 

 

 

 

 

See accompanying notes to interim condensed combined financial statements

F-2
Table of Contents

Gripevine, Inc.

INTERIM CONDENSED COMBINED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

FOR THE THREE AND NINE MONTHS ENDED NOVEMBER 30, 2017 AND 2016 (UNAUDITED)

(Expressed in US dollars)

 

 

For the

Three Months

Ended

November 30,

2017

 

 

For the

Three Months

Ended

November 30,

2016

 

 

For the

Nine Months

Ended

November 30,

2017

 

 

For the

Nine Months

Ended

November 30,

2016

 

 

 

$

 

 

$

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

REVENUE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock based compensation [Note 7]

 

 

155,429

 

 

 

9,673,604

 

 

 

744,399

 

 

 

29,020,811

 

Research and development expenses [Note 8]

 

 

146,684

 

 

 

318,430

 

 

 

599,766

 

 

 

778,582

 

General and administrative expenses

 

 

118,262

 

 

 

77,895

 

 

 

300,818

 

 

 

290,323

 

TOTAL OPERATING EXPENSES

 

 

420,375

 

 

 

10,069,929

 

 

 

1,644,983

 

 

 

30,089,716

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income taxes

 

 

 

 

 

 

 

 

 

 

 

 

NET LOSS

 

 

420,375

 

 

 

10,069,929

 

 

 

1,644,983

 

 

 

30,089,716

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Translation adjustment

 

 

79,679

 

 

 

(21,478)

 

 

(104,305)

 

 

(18,539)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COMPREHENSIVE LOSS

 

 

500,054

 

 

 

10,048,451

 

 

 

1,540,678

 

 

 

30,071,177

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOSS PER SHARE, BASIC AND DILUTED

 

 

0.004

 

 

 

0.084

 

 

 

0.013

 

 

 

0.251

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING

 

 

122,749,321

 

 

 

120,000,000

 

 

 

120,909,775

 

 

 

120,000,000

 

See accompanying notes to interim condensed combined financial statements

F-3
Table of Contents

Gripevine, Inc.

INTERIM CONDENSED COMBINED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED NOVEMBER 30, 2017 AND 2016 (UNAUDITED)

(Expressed in US dollars)

 

 

For the Nine

Months

Ended

November 30,

2017

 

 

For the Nine

Months

Ended

November 30,

2016

 

 

 

$

 

 

$

 

 

 

 

 

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss

 

 

(1,644,983)

 

 

(30,089,716)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Stock based compensation

 

 

744,399

 

 

 

29,020,811

 

Depreciation

 

 

17,780

 

 

 

7,963

 

 

 

 

 

 

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Prepaid expenses and other receivables

 

 

(11,105)

 

 

(2,641)

Accounts payable

 

 

3,836

 

 

 

20,841

 

Accrued liabilities

 

 

(52,678)

 

 

(3,824)

Net cash used in operating activities

 

 

(942,751)

 

 

(1,046,566)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Purchase of equipment

 

 

(11,998)

 

 

(14,486)

Net cash used in investing activities

 

 

(11,998)

 

 

(14,486)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Proceeds from issuance of shares

 

 

873,163

 

 

 

 

Loans payable

 

 

166,687

 

 

 

951,666

 

Due to related parties

 

 

(8,961)

 

 

(47,034)

Due to a shareholder

 

 

69,552

 

 

 

159,792

 

Net cash provided by financing activities

 

 

1,100,441

 

 

 

1,064,424

 

 

 

 

 

 

 

 

 

 

Net increase in cash during the period

 

 

145,692

 

 

 

3,372

 

 

 

 

 

 

 

 

 

 

Effect of foreign currency translation

 

 

(25,288)

 

 

(1,575)

 

 

 

 

 

 

 

 

 

Cash, beginning of period

 

 

32,678

 

 

 

23,926

 

Cash, end of period

 

 

153,082

 

 

 

25,723

 

See accompanying notes to interim condensed combined financial statements

F-4
Table of Contents

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

1. NATURE OF OPERATIONS

Gripevine, Inc. (formerly Baixo Relocation Services, Inc. (the "Company") was incorporated in the state of Nevada on January 7, 2014. The Company operated as a relocation service provider for clients moving to the State of Goa, India and ceased this business and engaged in developing and building an online resolution platform after the Share Exchange Agreement as explained in the subsequent paragraphs. The Company's fiscal year-end is February end.

MBE Holdings Inc. (“MBE”) was incorporated as a limited liability company on April 13, 2010 under the laws of the State of Delaware. MBE is engaged in research and development activities to offer an online complaint resolution platform for consumers and business, including ratings, reviews and polling’s. As such, its efforts to date have been devoted in building technology that enables access to this market through the development of a tangible product.

As explained in Note 7 to the condensed combined financial statements, on February 28, 2017, the Company and MBE and the shareholders of MBE who collectively own 100% of MBE entered into and consummated transactions pursuant to a Share Exchange Agreement, whereby the Company agreed to issue to the MBE shareholders an aggregate of approximately 5,248,626 shares of its common stock, par value $0.001, in exchange for 100% of equity interests of MBE held by the MBE shareholders. As a result of the share exchange, MBE became a wholly owned subsidiary of Gripevine.

As a result of the Share Exchange Agreement, the acquisition transaction has been accounted for as a common control transaction in accordance with the Financial Accounting Standards Board (ASC 805-50, Business Combinations – Common control transactions). The Company has evaluated the guidance contained in ASC 805 with respect to the combinations among entities or businesses under common control and conclude that since the majority shareholder of the Company and MBE are same, therefore, this is a common control transaction and do not result in a change in control at the ultimate parent or the controlling shareholder level.

Consequently, common control transactions are not accounted for at fair value. Rather, common control transactions are generally accounted for at the carrying amount of the net assets or equity interests transferred. Any differences between the proceeds received or transferred and the carrying amounts of the net assets are considered equity transactions that would be eliminated in consolidation, and no gain or loss would be recognized in the condensed combined financial statements of the ultimate parent. Resultantly, the financial position and the results of operations of Gripevine and MBE are combined together as if they were operating as one entity from the beginning.

2. BASIS OF PRESENTATION AND COMBINATION

The accompanying unaudited condensed combined financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) for interim financial information and the Securities Exchange Commission (“SEC”) instructions to Form 10-Q and Article 8 of SEC Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements and should be read in conjunction with the Company’s audited combined financial statements for the years ended February 28, 2017 and February 29, 2016 and notes thereto included in the Form 10-K filed with the SEC on June 14, 2017. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of combined financial position and results of operations for the interim periods presented have been reflected herein. Operating results for the nine months ended November 30, 2017, are not necessarily indicative of the results that may be expected for the year ending February 28, 2018.

F-5
Table of Contents

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

2. BASIS OF PRESENTATION AND COMBINATION (continued)

As explained above in Note 1 to the unaudited condensed combined financial statements, as a result of the Share Exchange Agreement, the acquisition transaction has been accounted for as a common control transaction in accordance with the Financial Accounting Standards Board (ASC 805-50, Business Combinations – Common control transactions). Consequently, the condensed combined financial statements have been prepared as if the Company and MBE were a single organization by the aggregation of their financial statements from the beginning of the previous period and the elimination of transactions and balances between them.

3. GOING CONCERN

The unaudited condensed combined financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses from operations and as at November 30, 2017 and February 28, 2017 had a working capital deficiency of $2,745,680 and $2,618,599, respectively and an accumulated deficit of $48,279,952 and $46,634,969 respectively. Management anticipates the Company will attain profitable status and improve its liquidity through continued business development and additional debt or equity investment in the Company. The Company’s continued existence is dependent upon its ability to continue to execute its operating plan and to obtain additional debt or equity financing. There can be no assurance that the necessary debt or equity financing will be available, or will be available on terms acceptable to the Company, in which case the Company may be unable to meet its obligations. Should the Company be unable to realize its assets and discharge its liabilities in the normal course of business, the net realizable value of its assets may be materially less than the amounts recorded in the condensed combined financial statements. The condensed combined financial statements do not include any adjustments relating to the recoverability of recorded asset amounts that might be necessary should the Company be unable to continue in existence.

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

The preparation of unaudited condensed combined financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed combined financial statements and the reported amounts of revenues and expenses during the reporting period. Areas involving significant estimates and assumptions include: deferred income tax assets and related valuation allowance and accruals. Actual results could differ from those estimates. These estimates are reviewed periodically, and, as adjustments become necessary, they are reported in earnings in the period in which they become known.

Loss Per Share

The Company has adopted the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 260-10 which provides for calculation of “basic” and “diluted” earnings per share. Basic earnings per share includes no dilution and is computed by dividing net income or loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. Diluted earnings per share exclude all potentially dilutive shares if their effect is anti-dilutive. There were no potentially dilutive shares outstanding as at November 30, 2017 and 2016.

Fair Value of Financial Instruments

ASC 820 defines fair value, establishes a framework for measuring fair value and expands required disclosure about fair value measurements of assets and liabilities. ASC 820-10 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820-10 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

 
F-6

Table of Contents

 

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Three(c) At August 31, 2022, the Company owed $-0- (February 28, 2022 - $118,125) under a loan agreement dated June 17, 2020 which is unsecured, bears interest at 5% per annum, and has a 2% penalty fee for non-repayment on the due date which was July 31, 2020. The penalty fee is calculated at time of repayment and Nine Months Ended November 30, 2017

(Expressed in US dollars)

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

·

Level 1 – Valuation based on quoted market prices in active markets for identical assets or liabilities.

·

Level 2 – Valuation based on quoted market prices for similar assets and liabilities in active markets.

·

Level 3 – Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management’s best estimate of what market participants would use as fair value.

In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant toprincipal amount outstanding and any accrued interest thereon. As consideration for making the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments or interest rates that are comparable to market rates. These financial instruments include cash and accounts payable. The Company's cash, which is carried at fair value, is classified as a Level 1 financial instrument. The Company’s bank accounts are maintained with financial institutions of reputable credit, therefore, bear minimal credit risk.

Stock Based Compensation

The Company accounts for share-based payments in accordance with the provision of ASC 718, which requires that all share-based payments issued to acquire goods or services, including grants of employee stock options, be recognized in the statement of operations based on their fair values, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Compensation expense related to share-based awards is recognized over the requisite service period, which is generally the vesting period. The Company accounts for stock based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the guidelines in ASC 505-50. The Company issues compensatory shares for services including, but not limited to, executive, management, accounting, operations, corporate communication, financial and administrative consulting services.

Recently Issued Accounting Pronouncements

In May 2017, an accounting pronouncement was issued by the Financial Accounting Standards Board (“FASB”) ASU 2017-09, “Compensation - Stock Compensation: Scope of Modification Accounting.” ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The updated guidance is effective for interim and annual periods beginning after December 15, 2017, and early adoption is permitted. The adoption of this pronouncement will not have a material impact on the unaudited condensed combined financial position and/or results of operations.

On January 1, 2017,loan, the Company adopted the accounting pronouncement issued by the FASB to simplify the presentation of deferred income taxes within the balance sheet. This pronouncement eliminates the requirement that deferred tax assets and liabilities are presented as current or noncurrent based on the nature of the underlying assets and liabilities. Instead, the pronouncement requires that all deferred tax assets and liabilities, including valuation allowances, be classified as noncurrent. We adopted this pronouncement on a retrospective basis. The adoption of this guidance did not have a material impact on the Company’s unaudited condensed combined financial position and/or results of operations.

F-7
Table of Contents

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

On January 1, 2017, the Company adopted the accounting pronouncement issued by the FASB to simplify the accounting for goodwill impairment. This guidance eliminates the requirement that an entity calculate the implied fair value of goodwill when measuring an impairment charge. Instead, an entity would record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value. The Company adopted this pronouncement on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s unaudited condensed combined financial position and/or results of operations.

In February 2016, an accounting pronouncement was issued by the FASB to replace existing lease accounting guidance. This pronouncement is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet for most leases. Expenses associated with leases will continue to be recognized in a manner similar to current accounting guidance. This pronouncement is effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted. The adoption is required to be applied on a modified retrospective basis for each prior reporting period presented. The Company has not yet determined the effect that the adoption of this pronouncement may have on its unaudited condensed combined financial position and/or results of operations.

5. EQUIPMENT

 

 

As at

November 30,

 

 

As at

February 28,

 

 

 

2017

 

 

2017

 

 

 

$

 

 

$

 

Furniture

 

 

38,192

 

 

 

31,889

 

Computer equipment

 

 

32,207

 

 

 

24,864

 

Total cost

 

 

70,399

 

 

 

56,753

 

Less: Accumulated depreciation

 

 

(33,390)

 

 

(15,098)

 

 

 

37,009

 

 

 

41,655

 

6. LOANS PAYABLE/DUE TO RELATED PARTIES / DUE TO A SHAREHOLDER

Loans payable

Loans payable represents advances from a related corporation to meet the working capital requirements of the Company. These advances are interest free, unsecured and are repayable on demand.

Due to related parties and due to a shareholder

The balances due to related parties and a shareholder are mainly in connection with the consulting services and financing provided for the development of an online complaint resolution platform as explained in Note 1 to the condensed combined financial statements. These balances are interest free, unsecured and are repayable on demand.

F-8
Table of Contents

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

7. STOCKHOLDERS’ DEFICIENCY

Share Exchange Agreement

On February 28, 2017, the Company, MBE and the shareholders of MBE entered into a Share Exchange Agreement (the “Share Exchange Agreement”). The Board of Directors of the Company approved the execution and consummation of the transaction under the Share Exchange Agreement on February 28, 2017.

In accordance with the terms and provisions of the Share Exchange Agreement, the Company is to issue an aggregate of 5,248,626 shares of its restricted common stock to the MBE Shareholders in exchange for 157,458,778 of the total issued and outstanding shares of MBE (constituting 100%), thus making MBE its wholly-owned subsidiary. The Board of Directors of the Company and MBE deemed it in the best interests of the respective shareholders to enter into the Share Exchange Agreement pursuant to which the Company would acquire all the technology and assets and assume all liabilities of MBE.

Authorized stock

On October 31, 2016, the Board of Directors of the Company authorized an increase in the Company's5,882 shares of common stock to three hundred million (300,000,000) shares with para fair value remainingof $24,500 and granted 2,941 stock options with a fair value of $11,835 exercisable at $0.001 and creation of twenty million (20,000,000) shares of preferred stock, par value $0.001.$17.00 per share expiring on June 17, 2023. On November 4, 2016,October 5, 2020, the Company filed a Certificate of Amendment with the Nevada Secretary of State increasing its authorized capital to 300,000,000issued 17,648 shares of common stock parwith a fair value $0.001,of $25,500 as payment for $3,984 interest and 20,000,000 sharespenalties due on this loan and extension of preferred stock, par value $0.001 (the “Amendment).the maturity date of the loan to November 25, 2020, resulting in a loss on settlement of debt of $21,516.

(d) At August 31, 2022, the Company owed $nil (February 28, 2022 - $196,875) under a loan agreement dated October 5, 2020. The Amendmentloan was effective with the Nevada Secretary of Statedue on November 4, 2016 when the Certificate of Amendment was filed. The Amendment was approved25, 2020 and secured by the Board of Directors pursuant to written consent resolutions dated October 31, 2016 and further approved by the shareholders holding a majority of the total issued and outstanding588,235 shares of common stock of the Company pursuant to written consent resolutions dated October 31, 2016.owned by the President of the Company. The Company issued 17,648 shares of common stock in lieu of any interest and late payment penalties.

 

Common stock issued(e) At August 31, 2022, the Company owed $nil (February 28, 2022 - $94,500) under a loan agreement dated December 1, 2020. The loan is unsecured, non-interest bearing, unsecured, and outstandingdue on demand.

 

On May(f) As of August 31, 20162022, the Company owed $-0- (February 28, 2022 - $23,625) under a loan agreement dated December 1, 2020 which is unsecured, bears interest at 5% per annum, and effective October 3, 2016, the Company’s previous majority shareholder, sole executive officer and memberhad a maturity date of June 1, 2021. The interest rate increases to 12% per annum on non-repayment of the Board of Directors, entered into certain stock purchase agreements (collectively,principal amount outstanding and interest thereon by the “Stock Purchase Agreements”)due date.  This loan was assumed by buyer with certain individuals and/or entities (collectively,MBE spinoff.

5. Related Party Transactions

(a) At August 31, 2022, the “Investors”). In accordance withCompany owed $1,022,289 (February 28, 2022 – $1,123,076) to the terms and provisions of the Stock Purchase Agreements, the then majority shareholder sold and transferred at a per share price of $0.037 the control blockPresident of the Company consisting of 5,000,000 shares of restricted common stockwhich is unsecured, non-interest bearing, and representing approximately 62.5%due on demand.

(b) At August 31, 2022, the Company owed $143,928 (February 28, 2022 - $117,491) under various loan agreements which are unsecured, bear interest at 5% per annum, and have different maturity dates respectively. The interest rate increases to 12% per annum on non-repayment of the total issuedprincipal amount outstanding and outstanding shares of common stock.

Duringinterest thereon by the quarter period ended, November 30, 2017,due date. The new interest is accrued till final repayment and is based on the Company issued 4,720,532 shares in connectionprincipal amount outstanding. The loan agreements are with the Share Exchange Agreement as explained above. The remaining shares of 528,094 are included in common stock to be issued.

As at November 30, 2017 the Company has 124,720,532 outstanding common stock comprising of 79,717,199 restricted stock and 45,003,333 unrestricted stock. As at February 28, 2017, the Company has 120,000,000 outstanding common stock comprising of 75,000,000 restricted stock and 45,000,000 unrestricted stock.

Common stock to be issued

Common stock to be issued of 3,022,844 shares comprise of:

·528,094 shares in connection with the “Share Exchange Agreement” as explained above.

·During June and August 2017, the Company sold 1,445,657 shares of common stock to nine investors through a private placement at a price of $0.35 per common stock and received gross proceeds of $505,980.

·During September, October and November 2017, the Company sold 1,049,093 shares of common stock to six investors through a private placement at a price of $0.35 per common stock and received gross proceeds of $367,183.

F-9
Table of Contents

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

7. STOCKHOLDERS’ DEFICIENCY (continued)

Preferred stock

On April 20, 2017, the Board of Directors authorized the issuancespouse of the 1,000,000 shares of Series A Preferred Stock to its sole executive officer and member of the Board of Directors in consideration of his services performed during the year ended February 28, 2017. These preferred stocks contain certain rights and preference as detailed below:

·

In the event of acquisition of the Company, the preferred stock holder to receive 20% of the aggregate valuation of such merger;

·

The holder can convert each share of preferred stock into 100 shares of common stock; and

·

Each holder of preferred stock shall be entitled to cast 200 votes.

The fair value of these 1,000,000 preferred stock amounting to $38,694,414 was determined by an independent valuation using the assumptions i. e. conversion value, control premium of 11.15% based on similar publicly trading companies, voting and sale/merger rights of the stock and stock price of $0.69. As the issuance of preferred stock related to past services, therefore, this amount was recorded as stock based compensation in the combined statements of operations during the previous year ended February 28, 2017. The charge relating to three and nine months ended November 30, 2016 amounts to $9,673,604 and $29,020,811.

Warrants

On December 1, 2016, the Company issued 18,275,000 warrants to certain shareholders of the Company for their services for the year ended February 28, 2017. These warrants have a strike price of $0.40 and will expire on December 1, 2019. The fair value of these warrants was measured at the date of grant using the Black-Scholes option pricing model using the following assumptions:

·Forfeiture rate of 0%;

·Stock price of $0.12 per share;

·Exercise price of $0.4 per share;

·Volatility at 265.20%;

·Risk free interest rate of 1.45%;

·Expected life of 3 years; and

·Expected dividend rate of 0%

At grant date the fair value of these warrants were determined at $2,110,333. As the issuance of warrants related to past services, therefore, this amount was recorded as stock based compensation in the combined statements of operations during the year (fourth quarter) ended February 28, 2017.

As at November 30, 2017 and February 28, 2017, there were 18,275,000 warrants were outstanding, fully vested and with a remaining contractual life term of 2.00 and 2.75 years, respectively.

Stock Based Options

On August 16, 2017, the Company approved Directors, Officers, Employees and Consultants Stock Option Plan, under which it authorized 50,000,000 options and issued 5,486,500 options. This plan was established to enable the Company to attract and retain the services of highly qualified and experience directors, officers, employees and consultants and to give such person an interest in the successPresident of the Company.

 

(c) At August 31, 2022, the Company owed $13,045 (February 28, 2022 - $nil) to a related company that is majority owned by multiple members on the board of director of the Company.

(d) At August 31, 2022, the Company owed $-0- (February 28, 2022 – $27,999) to the former Chief Operating Officer (“COO”) of the Company. The amount owing is included in accounts payable and accrued liabilities.

(e) During the six months ended August 31, 2022, the Company incurred $47,196 (2021 – $96,588) in research and development fees to the President of the Company.

(f) During the six months ended August 31, 2022, the Company incurred $nil (2021 - $12,074) in administrative fees included in general and administrative to the former office manager who is also the spouse of the President of the Company.

(g) During the six months ended August 31, 2022, the Company recognized stock-based compensation of $nil (2021 - $77,345) to the President, former COO, and directors of the Company. The Company also recognized stock-based compensation of $nil (2021 - $18,561) in general and administrative to the spouse of the President of the Company

F-10F-7

Table of Contents

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

7. STOCKHOLDERS’ DEFICIENCY (continued)

On November 27, 2017, the Company approved the issue of a second tranche of 120,000 options to a new Director of the Company pursuant to the Directors, Officers, Employees and Consultants Stock Option Plan, under which it authorized 50,000,000 options.

As at November 30, 2017, the company has issued 5,606,500 options.

The fair value of each option granted is estimated at the time of grant using Black-Scholes option pricing model with the following assumptions:

·Forfeiture rate of: Tranche 1- 0%; Tranche 2 – 0%

·Stock price of: Tranche 1 - $0.20 per share; Tranche 2 - $0.20 per share

·Volatility at: Tranche 1 - 291%; Tranche 2 – 259%

·Market price of: Tranche 1 - $0.20 per share; Tranche 2 - $0.20 per share

·Risk free interest rate of: Tranche 1 - 1.49%; Tranche 2 – 1.62%

·Expected life of: Tranche 1 - 5 years; Tranche 2 – 5 years

·Expected dividend rate of: Tranche 1 - 0%; Tranche 2 – 0%

·Fair value of options of: Tranche 1 - $0.20; Tranche 2 - $0.20

  

For Tranche 1, 50% of the grants will vest immediately and 50% will vest one year from grant date and for Tranche 2, 100% of the grants vest immediately.

All grants will expire on the fifth anniversary of the grant date. The risk-free interest rate is based on the yield of U.S. Treasury securities that correspond to the expected holding period of the options. The volatility was determined based on company’s historical stock prices. The expected forfeiture (attrition) rates were based on the position of the consultants receiving the options. The dividend yield was based on an expected future dividend rate for the period at the time of grant.6. Stock Options

 

The following table summarizes the continuity of stock option activities of the Company:options:

 

 

Number of Options

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value

 

Balance – February 28, 2022

 

 

353,956

 

 

 

17.00

 

 

-

 

Cancelled/Forfeited

 

 

(353,956)

 

 

17.00

 

 

-

 

Balance – August 31, 2022

 

––

 

 

 

 

 

 

-

 

7. Discontinued Operations

 

 

 

Number

of options

 

 

Weighted average exercise

price ($)

 

Granted

 

 

5,606,500

 

 

 

0.200

 

Excercised

 

 

 

 

 

0.200

 

Outstanding as of November 30, 2017

 

 

5,606,500

 

 

 

0.200

 

On June 27, 2022, the Company finalized the sale of MBE Holdings, Inc. As of June 27, 2922, the Company transferred all the equity in MBE Holdings, Inc. to Richard Hue in exchange for Notes in the amount of 4,050,978 which were assigned from the following note holders:

 ,

Lender

 

 Face  Amount U.S. $

 

Harbour Capital (1)

 

$2,124,022

 

Red Trade Ventures (1)

 

 

576,522

 

Richard Hue (1)

 

 

1,039,682

 

Richard Hue

 

 

11,283

 

Harbour Capital (1)

 

 

153,203

 

Enza Agosta (1)

 

 

78,125

 

Enza Agosta

 

 

53,000

 

Enza Agosta (1)

 

 

6,641

 

Enza Agosta

 

 

8,500

 

Total

 

$4,050,978

 

(1)

These notes originated in Canadian funds and are converted to US dollars.

In conjunction with the above, MBE Holdings, Inc assumed flooidCX’s payable in the amount of $332,642.82 and two notes payable totaling $429,682.

 

The fair valueCompany has recognized the sale of tranche 1 options atMBE Holding, Inc. into discontinued operations in accordance with ASC No. 205-20, Discontinued Operations. As such, the issuance date was determined at $1,087,917 outhistorical results of which $136,076 and $725,046 were expensed during the three and nine months ended November 30, 2017 respectively based on vesting period and were included in stock based compensation with corresponding credit to additional paid-in-capital.4,813,303.54 have been adjusted for comparability purposes.

 

The fair valuefollowing financial information presents the statements of tranche 2 options atoperations of MBE Holdings, Inc. for the issuance date was determined at $19,353six months ended August 31, 2022 and expensed entirely in the quarter ended November 30, 2017.2021.

 

As at November 30, 2017 there were 5,606,500 stock options outstanding, 2,863,250 vested and with a remaining contractual life term of 4.71 years

 

 

FOR THE SIX MONTHS ENDED AUGUST 31,

 

 

 

2022

 

 

2021

 

TOTAL REVENUE

 

 

 

 

8,803

 

OPERATING EXPENSES

 

 

 

 

 

 

 

General and administrative expense

 

 

34,752

 

 

 

113,278

 

Research and development

 

 

138,449

 

 

 

162,584

 

TOTAL OPERATING EXPENSES

 

 

173,201

 

 

 

275,862

 

OPERATING LOSS

 

 

173,201

 

 

 

267,059

 

Finance Costs

 

 -

 

 

-

 

Other

 

 

 

 

 

 

 

 

TOTAL OTHER EXPENSE

 

-

 

 

-

 

NET LOSS OF DISCONTINUED OPERATIONS

 

$(173,201)

 

$(267,059)

 

 
F-11

F-8

Table of Contents

 

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

8. RELATED PARTY TRANSACTIONS AND BALANCES

The Company’s transactions with related parties were carried out on normal commercial terms and in the normal course of the Company’s business. Other than disclosed elsewhere in the unaudited condensed combined financial statements, the related party transactions and balances are as follows:

Research and development expenses for the three and nine months ended November 30, 2017 include consulting charges from shareholders and related parties of $54,524 and $182,619, respectively (2016: $104,267 and $273,335 respectively).

9. COMMITMENTS

On March 8, 2016, the Company entered into an operating lease contract for its office premises in Oakville, Ontario for a three year and eight months term commenced from May 1, 2016. The monthly lease payment is between $3,350 to $4,890 plus applicable taxes.

On December 6, 2016, the Company entered into a second operating lease contract for its additional office premises in Oakville, Ontario for a three year term commencing from January 1, 2017. The monthly lease payment is between $2,500 to $3,800 plus applicable taxes.

10. SUBSEQUENT EVENTS

The Company’s management has evaluated subsequent events up to January 16, 2018, the date the condensed combined financial statements were issued, pursuant to the requirements of ASC 855 and has determined the following material subsequent events:

During December 2017, the Company sold 428,571 shares of common stock to one investor through a private placement at a price of $0.35 per common stock and received gross proceeds of $150,000.

During December 2017, our Board of Directors (the “Board”) approved an aggregate of 5,674,944 shares of our restricted common stock to certain non-affiliated consultants (the “Consultants”) in consideration of various services rendered to the Company. As of the date of this Quarterly Report, these shares are not issued.

F-12
Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion provides an analysis of the Company’s financial condition and results of operations and should be read in conjunction with the Interim Condensed CombinedConsolidated Financial Statements and notes thereto included in Item 1 of Part I of this Quarterly Report on Form 10-Q and with the Company’s Annual Report on Form 10-K filed for the fiscal year ended February 28, 2017.2021. The discussion contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors.

 

Overview

 

Gripevine, Inc.flooidCX Corp., formerly known as Gripevine, Inc. (the “Company”), was incorporated under the name Baixo Relocation Services, Inc. (the "Company"), was incorporated in the state of Nevada on January 7, 2014. On May 31, 2016, Rosy Rodrigues (“Rodrigues”), our prior majority shareholder, sole executive officer and member of the Board of Directors, entered into those certain stock purchase agreements effective October 3, 2016 (collectively, the “Stock Purchase Agreements”) with certain individuals and/or entities (collectively, the “Investors”). In accordance with the terms and provisions of the Stock Purchase Agreements, Rodrigues sold and transferred the control block of the Company consisting of 5,000,000 shares of restricted common stock at a per share price of $0.037, representing approximately 62.5% of the total issued and outstanding shares of common stock and resulting in a change in control. The Company operated as a relocation service provider for clients moving to the State of Goa, India.

Effective February 28, 2017, we entered into a share exchange agreement (the “Share“MBE Exchange Agreement”) with MBE Holdings Inc., a private corporation organized under the laws of Delaware (“MBE”) and the shareholders of MBE (the “MBE Shareholders”), pursuant to which ShareMBE Exchange Agreement we acquired all the technology and assets and assumeassumed all liabilities of MBE, and MBE became our wholly-owned subsidiary. In accordance with the terms and provisions of the ShareMBE Exchange Agreement, an aggregate of 5,248,626 (pre-reverse split) shares of our restricted common stock are to bewere issued to the MBE Shareholders in exchange for 157,458,778 of the total issued and outstanding shares of MBE. As

Effective March 18, 2019, we changed our name to flooidCX Corp. pursuant to Certificate of Amendment to our Articles of Incorporation filed with the Nevada Secretary of State. The name of the dateCompany was changed as part of this Quarterly Report, an aggregate 4,720,532our rebranding, which better reflects our new business direction into the customer care and feedback solutions space – offering easy to adapt customer care and feedback solutions to enterprises of all sizes.

On May 17, 2019, we entered into a Share Exchange Agreement (the “R1 Exchange Agreement”) with the stockholders of Resolution 1, Inc., a Delaware corporation (“R1”), to acquire all of the outstanding shares of R1 in exchange for 10,000,000 (pre-reverse split) restricted shares of our restricted common stock have been issued to the MBE Shareholders. See “Part II. Item 2. Unregistered Sales of Equity Securities(the “Acquisition”). R1 has developed a comprehensive customer care and Use of Proceeds – Share Exchange Agreement”.

MBE was formedfeedback management platform, which is delivered as a limited liability company on April 13, 2010,cloud-based, software as a service solution. R1 was founded in August 2012 by Richard Hue, the CEO and subsequently converted into a corporation on August 3, 2012, underdirector of our Company. The Acquisition was approved by the lawsindependent members of the Stateboard of Delaware. MBE is engaged in research and development activities to offer an online complaint resolution platform for consumers and business, including ratings, reviews and polling’s. As such, its efforts to date have been devoted in building technology that enables access to this market throughdirectors of the development of a tangible product. The Share Exchange Agreement resulted in a change in overall business operationsCompany. Since the majority shareholders of the Company bringing potential value to our shareholders. Followingand R1 are the Share Exchange Agreement, we ceased operationssame, this did not result in the change in control at the ultimate parent or the controlling shareholder level, and was accounted for as a relocation service provider and engaged in developing and building an online resolution platform.common control transaction.

 

SinceOn January 27, 2021, the Company’s common stock began trading on a 1-for-85 reverse stock split basis.

Our mission is to help businesses bring back the conversation with customers with innovative, simple to use solutions that empower both the businesses and customers to communicate and create positive outcomes. With the consummation of the ShareR1 Exchange Agreement resulting in MBER1 being our wholly-owned subsidiary, we have been involved in the ongoing developmentnow offer a suite of customer relationship management (CRM) solutions that enhances and marketing of “Gripevine”, which is a social customer experience platform for social customer service and consumer reviews. “Gripevine” includes a proprietary process to assist companies in resolving customer service complaints (the “Gripevine Proprietary Process” or “Gripevine”). The Gripevine Proprietary Process helps consumers achieve resolutions while enabling businesses to improve consumer loyalty. Our platform includes the handling of ratings, reviews, complaint resolution statuses whilebuilds upon our initial offering, data collection features such as scoring, polling, comments, voting, and credibility points – all with the aim of creating a home for connections, resolution, business improvement, and loyalty enhancement. Consumers with legitimate customer service complaints can post it (“plant a gripe”) and connect with companies who in turn can interact with their customers on a level playing field to find an amicable resolution.“GripeVine.”

 

Unlike other review sitesWe offer unified communications and collaboration online CRM solutions - GripeVine and Resolution1. GripeVine is a consumer-to-business platform that cater specificallyhelps build a customer feedback-minded community, focused on transparency, mutual respect and open communications among like-minded customers and businesses – all working together – to accumulatingfacilitate positive outcomes. It allows for private messaging between customers and displaying consumer feedback, the Gripevine business model offers significant value to both consumers and businesses. Management of the Corporation believesbusinesses for positive resolutions, so that the Gripevine Proprietary Process brings fairness and balance by: (i) ensuring users are real; (ii) allowing companies to reach out and verify customer identity; (iii) flagging as fake those consumers whobusinesses are not identifiable;forced to communicate via the comments section. Resolution1 functions as a cloud-based customer care and (iv) providing companies free accessfeedback workflow management platform, where businesses can manage the entire logistics of customer care, feedback or inquiries throughout their entire organizations. Businesses can respond quickly and accurately to their customers. Gripevine’s unique proposition incustomers, while keeping track of every customer interaction. The platform is designed to grow and scale, so that businesses of all sizes, from small to medium-size enterprises (SMEs) to large enterprises, can use this socialcloud-based customer experience space is to create consumer-company connections in order to drive loyalty through efficientcare and effective handling of online customer feedback and commentary.management system

 

5

Table of Contents

Results of Operations

 

The following discussions are based on our unaudited interim condensed combinedconsolidated financial statements, including our wholly owned subsidiary.wholly-owned subsidiaries. These charts and discussions summarize our unaudited interim consolidated financial statements for the three and nine month periodthree-month periods ended November 30, 2017 and November 30, 2016,August 31, 2022, and should be read in conjunction with the Company’s audited combinedconsolidated financial statements for the yearsyear ended February 28, 2017 and February 29, 20162022 and notes thereto included in the Form 10-K filed with the SEC on June 14, 2017.15, 2022.

 

The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. The Corporation’sOur actual results could differ materially from those discussed in the forward lookingforward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to those discussed below and elsewhere in this Quarterly Report on Form 10-Q. The financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles.

 

5
Table of Contents
Three-Month Period Ended August 31, 2022 Compared to Three-Month Period Ended August 31, 2021

 

Nine Month Period Ended November 30, 2017 ComparedRevenue. There was no revenue generated for the three months ended August 31, 2022, as compared to Nine Month Period Ended November 30, 2016$10,322 for the comparable period in 2021.

 

Total Revenue.We did not generate any revenue during the nine month periods ended November 30, 2017 or November 30, 2016.

Operating expenses.expenses. During the nine month periodquarter ended November 30, 2017,August 31, 2022, we incurred operating expenses in the amount of $1,644,983$206,153 compared to operating expenses incurred during the nine month periodquarter ended November 30, 2016August 31, 2021 of $30,089,716$278,772 (a decrease of $28,444,733)$72,619). Operating expenses include: (i) general and administrative of $300,818 (2016: $290,323)$70,697 (2021: $127,168); and (ii) research and development expenses of $599,766 (2016: $778,582); and (iii) stock based compensation of $744,399 (2016: $29,020,811)$135,456 (2021: $161,926). General and administrative expenses increaseddecreased by $10,495 mainly$56,471, due primarily to an increase in professional fees.resignation of COO and Admin Officer. Research and development expenses decreased by $178,816 based on streamlining$26,470 primarily due to a decrease in stock-based compensation to the servicesPresident and scopedirectors of workthe Company.

Net loss. The Company had a net loss of existing consultants. Stock based compensation also decreased by $28,276,412 mainly relating to (a) the fair value of $38,694,414$229,062 or $0.10 per share for which a charge for the ninethree months ended November 30, 2016 was $29,020,811 pertaining to the issuance of 1,000,000 shares of Series A Preferred Stock to Richard Hue, our President/Chief Executive Officer; and (b) the valuation of the grant of 5,606,500 stock options resulting in $744,399 expensed during the nine month period ended November 30, 2017.

Net Loss.Our net loss for the nine month period ended November 30, 2017 was $1,644,983August 31, 2022 compared to a net loss of $30,089,716 during the nine month period ended November 30, 2016 (a decrease in net loss of $28,444,733). We did not generate any revenue during the nine month periods ended November 30, 2017 and November 30, 2016, respectively.

Translation Adjustment.During the nine month period ended November 30, 2017, we incurred a translation adjustment of ($104,305) compared to ($18,539) incurred during the nine month period ended November 30, 2016 representing change in the foreign exchange rate as a result of translating transaction and balances of Canadian based subsidiary.

Comprehensive income (loss). Thus, this resulted in comprehensive loss of ($1,540,678)$478,936 or ($0.013)$0.14 per share for the nine month period ended November 30, 2017 compared to a comprehensive loss of ($30,071,177) or ($0.251) per share for the nine month period ended November 30, 2016. The weighted average number of shares outstanding was 120,909,775 for nine month periods ended November 30, 2017 compared to 120,000,000 for nine months period ended November 30, 2016.

Three Month Period Ended November 30, 2017 Compared to Three Month Period Ended November 30, 2016

Total Revenue.We did not generate any revenue during the three month periods ended November 30, 2017 or November 30, 2016.

Operating expenses. During the three month period ended November 30, 2017, we incurred operating expenses in the amount of $420,375 compared to operating expenses incurred during the three month period ended November 30, 2016 of $10,069,929 (a decrease of $9,649,554). Operating expenses include: (i) general and administrative of $118,262 (2016: $77,895); (ii) research and development expenses of $146,684 (2016: $318,430); and (iii) stock based compensation of $155,429 (2016: $9,673,604). General and administrative expenses increased by $40,367 mainly due to an increase in professional fees. Research and development expenses decreased by $171,746 based on streamlining the services and scope of work of existing consultants. Stock based compensation also decreased by $9,518,175 relating to: (a) the fair value of $38,694,414 for which a charge for the three months ended November 30, 2016 was $ 9,673,604 pertaining to the issuance of 1,000,000 shares of Series A preferred stock to Richard Hue, our President/Chief Executive Officer; and (ii) the valuation of the grant of 5,606,500 stock options resulting in $155,429 expensed during the three month period ended November 30, 2017.August 31, 2021.

 

Net Loss.Thus, during the three month period ended November 30, 2017, this resulted in a net loss of ($420,375) compared to a net loss of ($10,069,929) for the three month period ended November 30, 2016.

Translation Adjustment.During the three month period ended November 30, 2017, we incurred a translation adjustment of $79,679 compared to ($21,478) incurred during the three month period ended November 30, 2016 representing change in the foreign exchange rate as a result of translating transaction and balances of Canadian based subsidiary.

Comprehensive loss. Thus, this resulted in comprehensive loss of $500,054 or $0.004 per share for the three month period ended November 30, 2017 compared to a comprehensive loss of $10,048,451 or $0.084 per share for the three month period ended November 30, 2016. The weighted average number of shares outstanding was 122,749,321 for three month periods ended November 30, 2017 compared to 120,000,000 for three month period ended November 30, 2016.

6
Table of Contents

Liquidity and Capital Resources

 

Nine Month Period Ended November 30, 2017As of August 31, 2022

 

As at the nine month period ended November 30, 2017,August 31, 2022, our current assets were $184,873$12,077 and our current liabilities were $2,930,553,$5,269,525, which resulted in a working capital deficit of $2,745,680. As at the nine month period ended November 30, 2017, current assets were comprised of: (i) $153,082 in cash; and (ii) $31,791 in prepaid and other receivables. As at the nine month period ended November 30, 2017, current liabilities were comprised of: (i) $26,683 in accounts payable; (ii) $28,083 in accrued liabilities; (iii) $2,046,526 in loans payable; (iv) $174,904 due to related parties; and (v) $654,357 due to shareholder.$5,257,448 (February 28, 2022 - $5,029,152).

 

As of the nine month period ended November 30, 2017, our total assets were $221,882 comprised of: (i) current assets of $184,873; and (ii) equipment, net of depreciation of $37,009. The increase in total assets during the nine month period ended November 30, 2017 from fiscal year ended February 28, 2017 was primarily due to an increase in cash of $120,404.

As of the nine month period ended November 30, 2017, our total liabilities were $2,930,553 comprised of current liabilities. The increase of $258,995 in total liabilities during the nine month period ended November 30, 2017 from fiscal year ended February 28, 2017 was primarily due to an increase in loans payable of $223,573, accounts payable of $4,358 and amounts due to a shareholder of $85,810 offset by a decrease in accrued liabilities of $50,744 and due to related party of $4,002.

Stockholders’ deficit increased from ($2,576,944) for fiscal year ended February 28, 2017 to ($2,708,671) for the nine month period ended November 30, 2017.

Cash Flows from Operating Activities

 

We have generated negative cash flows from operating activities. For the nine month periodthree months ended November 30, 2017,August 31, 2022, net cash flows used in operating activities was ($942,751)$83,101 compared to ($1,046,566)$105,703 for the nine month periodthree months ended November 30, 2016. Net cash flows used in operating activities consisted primarily of net loss of ($1,644,983) (2016: $30,089,716), which was adjusted by stock based compensation of $744,399 (2016: $29,020,811) and depreciation of $17,780 (2016: $7,963). Net cash flows used in operating activities was further changed by: (i) an increase of $11,105 (2016: ($2,641)) in prepaid expenses and other receivables; (ii) an increase of $3,836 (2016: $20,841) in accounts payable; and (iii) a decrease of ($52,678) (2016: ($3,824)) in accrued liabilities.August 31, 2021.

 

Cash Flows from Investing Activities

For the nine month period ended November 30, 2017, we used cash of $11,998 (2016: $14,486) in investing activities, which consisted of purchase of equipment.

Cash Flows From Financing Activities

 

Net cash flows provided from financing activities during the nine month periodthree months ended November 30, 2017August 31, 2022 was $1,100,441,$87,759, which consisted of: (i) $873,163 inof proceeds from issuance of shares; (ii) $166,687 in loans payable; and (iii) $69,552 due tofrom a shareholder, which was offset by ($8,961) due to a relatedthird party. During the nine month periodthree months ended November 30, 2016,August 31, 2021, cash flows provided by financing activities was $1,064,424,$99,443, which consisted of $951,666 inproceeds from loans payablefrom third party and $159,792 due to a shareholder, which was offset by ($47,034) due to related parties.party.

 

6

Material Commitments

Table of Contents

 

The balances due to related parties and shareholder are interest free, unsecured and are repayable on demand. The balances due to related parties and shareholders are mainly in connection with the services and financing provided for the development of an online complaint resolution platform.

Off-Balance Sheet Arrangements

 

There were no off-balance sheet arrangements during the nine month periodthree months ended November 30, 2017August 31, 2022 that have, or are reasonably likely to have, a current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our interests.

 
7
Table of Contents

Plan of Operation

 

As at November 30, 2017,August 31, 2022, we had an accumulateda working capital deficit of $48,279,952$5,269,525 and we will require additional financing in order to enable us to proceed with our plan of operations.

Thus far, we believe that COVID-19 has not impacted our business negatively. As more businesses adopt virtual office operation models due to the risk of the virus, such adoption may in fact present us with more opportunities to offer businesses cost-effective, cloud-based solutions.

When we will require additional financing, there can be no assurance that additional financing will be available to us, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will not be able to meet our other obligations as they become due. We are pursuing various alternatives to meet our immediate and long-term financial requirements.

 

We anticipate continuing to rely on equity sales of our common stock in order to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of equity securities or arrange for debt or other financing to fund our planned business activities.

 

Our auditor has issued a going concern opinion. This means that there is substantial doubt that we can continue as an on-going business for the next twelve months unless we generate sufficient revenues. There is no assurance we will ever reach that point. In the meantime, the continuation of the Company is dependent upon the continued financial support from our shareholders, our ability to obtain necessary equity financing to continue operations and the attainment of profitable operations.

 

Our operations and financial results are subject to various risks and uncertainties that could adversely affect our business, financial condition and results of operations.

 

We require approximately $150,000$1,500,000 for the next 12 months as a reporting issuer and additional funds are required. Before generation of revenue, theThe additional funding may come from equity financing from the sale of our common stock or loans from management, related third parties or related third parties. In the event we do not raise sufficient capital to implement its planned operations or divest, your entire investment could be lost.

 

7

Table of Contents

We have not paid any sums for public relations or investor relations.

Recent Accounting Pronouncements

 

Recent Accounting Pronouncements

Please seeAs reflected in Note 4 — “Recent Accounting Standards”2 of the Notes to the CondensedInterim Consolidated Financial Statements, for a discussion of the effects of recently issued accounting pronouncements.

Critical Accounting Policies

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States. To apply these principles, we must make estimates and judgments that affect our reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. In many instances, we reasonably could have used different accounting estimates and, in other instances, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates and judgments on historical experience and other assumptions that we believe to be reasonable at the time and under the circumstances, and we evaluate these estimates and judgments on an ongoing basis. We refer to accounting estimates and judgments of this type as critical accounting policies, judgments, and estimates. Management believes there have been no materialrecent accounting pronouncements or changes duringin accounting pronouncements that impacted the threenine months ended November 30, 20172021 or which are expected to impact future periods as follows:

In June 2016, the critical accounting policies reported in “Management’s DiscussionFASB issued ASU 2016-13, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments, which changes the impairment model for most financial assets. This Update is intended to improve financial reporting by requiring timelier recording of credit losses on loans and Analysisother financial instruments held by financial institutions and other organizations. The underlying premise of Financial Condition and Resultsthe Update is that financial assets measured at amortized cost should be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The allowance for credit losses should reflect management’s current estimate of Operations” in our Annual Report on Form 10-Kcredit losses that are expected to occur over the remaining life of a financial asset. The income statement will be affected for the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. The new standard is effective for fiscal year ended February 28, 2017.

8
Table of Contents
years and interim periods within those years beginning after December 15, 2022.

 

The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

  

Pursuant toAs required by Rule 13a-15(b)13a-15 under the Securities Exchange Act, of 1934 (“Exchange Act”), the Companyour management has carried out an evaluation, with the participation and under the supervision of the Company’s management, including the Company’s Chief Executive Officer (“CEO”)our chief executive officer and Chief Financial Officer (“CFO”) (the Company’s principalchief financial and accounting officer),officer, of the effectiveness of the Company’sdesign and operation of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Company’s CEO and CFO concluded that the Company’s disclosureAugust 31, 2022. Disclosure controls and procedures are not effective as of November 30, 2017refer to controls and other procedures designed to ensure that information required to be disclosed by the Company in the reports that the Company fileswe file or submitssubmit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms,formsof the SEC and that such information is accumulated and communicated to the Company’sour management, including the Company’s CEOour chief executive officer and CFO,chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure forcontrols and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the reason described below.desired control objectives, and management is required to apply its judgment in evaluating and implementing possible controls and procedures.

 

BecauseEvaluation of Disclosure Controls and Procedures 

Management conducted its evaluation of disclosure controls and procedures under the supervision of our limited operations, we have limited numberchief executive officer and our chief financial officer. Based upon, and as of employees which prohibits a segregationthe date of duties. In addition, we lack a formal audit committee with a financial expert. As we growthis evaluation, our Chief Executive Officer and expand our operations we will engage additional employees and experts as needed. However, there can be no assuranceChief Financial Officer concluded that our operationsdisclosure controls and procedures were ineffective as of August 31, 2022 due to the following material weaknesses that our management identified in our internal control over financial reporting as of August 31, 2022:

1)

We do not have an Audit Committee — While not being legally obligated to have an audit committee, it is the management’s view that such a committee, including a financial expert member, is an utmost important entity level control over the Company’s financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.

2)

We lack internal accounting personnel who possesses U.S GAAP knowledge and working experience.

We plan to take steps to remedy these material weaknesses as soon as practicable by implementing a plan to improve our internal control over financial reporting including, but not limited to, hiring additional staff who has U.S. GAAP knowledge and working experience and/or maintaining outside consultants experienced in U.S. GAAP financial reporting as well as in SEC reporting requirements.  Our management team will expand.continue to monitor and evaluate the effectiveness of our internal controls and procedures and our internal controls over financial reporting on an ongoing basis and is committed to taking further action to solve these deficiencies as necessary.

 

Evaluation of Changes in Internal Control Over over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). Internal control over financial reporting is a process designed by, or under the supervision of, our president (our principal executive officer and our principal accounting officer and principal financial officer), to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP. Internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of our company are being made only in accordance with authorizations of management and directors of our company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our company’s assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not provide absolute assurance that a misstatement of our financial statements would be prevented or detected. 

Further, the evaluation of the effectiveness of internal control over financial reporting was made as of a specific date, and continued effectiveness in future periods is subject to the risks that controls may become inadequate, because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management has conducted, with the participation of our president (our principal executive officer, our principal accounting officer and our principal financial officer), an evaluation of the effectiveness of our internal control over financial reporting as of August 31, 2022 in accordance with the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control — Integrated Framework. Based on this assessment, management concluded that as of August 31, 2022, there are material weaknesses, as identified above, in our internal controls over financial reporting.  The material weaknesses identified did not result in the restatement of any previously reported financial statements or related financial disclosure, nor does management believe that it had any affect on the accuracy of the Company’s financial statements for the current period.  

Our Company is in the process of adopting specific internal control mechanisms. Future controls, among other things, will include more checks and balances and communication strategies between the management and the board to ensure efficient and effective oversight over Company activities as well as more stringent accounting policies to track and update our financial reporting.

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal controlcontrols over financial reporting that occurred during the period covered by this reportthree months ended August 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
98

Table of Contents

  

PART II - OTHER INFORMATION

 

ITEM 1.LEGAL PROCEEDINGS

 

The Company currently is not a party to any legal proceedings and, to the Company’s knowledge; no such proceedings are threatened or contemplated.

 

ITEM 1A.RISK FACTORS

 

Not applicable.

 

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Consulting Agreements

During December 2017, our Board of Directors (the “Board”) approved to issue an aggregate of 5,674,944 shares of our restricted common stock to certain consultants (the “Consultants”) in consideration of various services rendered to the Company. As of the date of this Quarterly Report, these shares are not issued. The shares of restricted common stock are to be issued to the Consultants in reliance on the exemption from registration under by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”).

Private Placement

During the nine month period ended November 30, 2017 and to current date, we have engaged in private placements offerings of our shares of restricted common stock in reliance on Regulation S promulgated under the Securities Act.

During the nine month period ended November 30, 2017 pursuant to subscription agreements (“Subscription Agreements”), we sold an aggregate 2,494,750 shares of our restricted common stock in a private placement offering to certain non-U.S. investors at a price of $0.35 per share of common stock and received gross proceeds of $873,163. On December 15, 2017, the Board approved to issue an aggregate of 2,494,750 shares of common stock to the investors. As of the date of this Quarterly Report, these shares are not issued.

The foregoing description of the Subscription Agreement is not complete and is qualified in its entirety by reference to the full text of the Subscription Agreement, a form of which is filed as Exhibit 10.1 hereto and is incorporated by reference herein.

The securities referenced above were issued in reliance on the exemption from registration afford by Regulation S promulgated under the Securities Act as a transaction by an issuer not involving a public offering. Such shares of common stock have not been registered under the Securities Act or under any state securities laws and may not be offered or sold without registration with the United States Securities and Exchange Commission or an applicable exemption from the registration requirements. The investors acknowledged that the securities to be issued have not been registered under the Securities Act, that they understood the economic risk of an investment in the securities, and that they had the opportunity to ask questions of and receive answers from our management concerning any and all matters related to acquisition of the securities.

10
Table of Contents

Grant of Options

On November 27, 2017, the Board granted Ms. Helen Bernardino an option to purchase 120,000 shares of common stock of the Company, par value $0.001, at an exercise price of $0.20 per share, in connection with Ms. Bernardino’s appointment as a director of the Company. Such option shall have a term of five (5) years and vested immediately upon the effective date of her appointment, November 27, 2017. The securities were issued in reliance on the exemption from registration under by Section 4(a)(2) of the Securities Act.

Except as set forth in this Item 2, thereThere were no sales of unregistered securities sold by usthe Company during the quarter ended November 30, 2017 that were not otherwise disclosed in a Current Report on Form 8-K.August 31,2022.

  

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4.MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5.OTHER INFORMATION

 

See Part II, Item 2None.

9

Table of Contents

ITEM 6. EXHIBITS

The following exhibits are filed as part of this Form 10-Q 

11
Table of Contents

ITEM 6.EXHIBITS10-Q:

 

Exhibit No.

Number

 

Description of Exhibits

 

10.13.1

 

Subscription Agreement betweenArticles of Incorporation of Baixo Relocation Services Inc. incorporated herewith as filed as an Exhibit to the Company and non-U.S. investors+Registration Statement on Form S-1 on June 11, 2014.

3.1.2

Amendment to Articles of Incorporation of Baixo Relocation Services Inc. incorporated herewith as filed as an Exhibit to the Current Report on Form 8-K on December 29, 2016.

3.1.3

Designation of Series A Preferred Stock filed with the Nevada Secretary of State on April 20, 2017 incorporated herewith as filed as an Exhibit to the Form 8-K on May 9, 2017.

3.1.4

Certificate of Amendment to Articles of Incorporation incorporated herewith as filed as an Exhibit to the Current Report on Form 8-K on March 21, 2019.

3.2

Bylaws of Baixo Relocation Services Inc. incorporated herewith as filed as an Exhibit to the Registration Statement on Form S-1 on June 11, 2014.

10.3

March 15, 2021 loan agreement for Cdn$100,000 incorporated herewith as filed as an Exhibit to the Form 10-Q on July 15, 2021.

31.1

 

Section 302 Certification of Principal Executive Officer+Officer pursuant to 18 U.S.C.§ 1350, as adopted pursuant to § 302 of the Sarbanes-Oxley Act of 2002.

31.2

 

Section 302 Certification of Principal Financial Officer+

32.1

 

Section 906 Certification of Principal Executive Officer+Officer and Principal Financial Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002.

101**

Interactive data files pursuant to Rule 405 of Regulation S-T.

101.INS

 

Inline XBRL Instance Document +(the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document +Document.

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document +Document.

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB

 

Inline XBRL Taxonomy Extension Labels Linkbase Document +Document.

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document +Document.

101.DEF

 

XBRL Definition Linkbase Document +

104

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

_______________________ 

+filed herewith

**

XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

 
1210

Table of Contents

  

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Reportreport to be signed on its behalf by the undersigned, thereunto duly authorized.

 

GRIPVINE INC.flooidCX Corp.

 

January 16, 2018October 19, 2022

By:

/s/ Richard HueDennis M. Danzik

 

Richard HueDennis M. Danzik

 

Chief Executive Officer, President, Secretary, Treasurer,

Chief Financial Officer and Director

 

11

 

 

13